Home Press Articles

Press Articles

Press Articles

SciDev.net [February 1, 2010]
"Challenge: Potential Drug Targets for Kinetoplastid Infectious Diseases"
Click here to access the article
 

Press Articles

De Standaard [December 22, 2009]
"Neglected diseases claim 10,000 of lives every year" - "Verwaarloosde ziektes eisen tienduizenden levens per jaar" (Flemish version)
Click here to read the article
   

Press Articles

The George Institute - G-Finder [December 15, 2009]
"US$3billion spent on neglected disease R&D in 2008"
Click here to read the article
   

Press Articles

CheckOrphan [May 27, 2010]
"Sanofi-Aventis Receives Award for Innovative Malaria Access to Medicines Partnership Programme"
Click here to read the article
   

Press Articles

BILAN [May 19, 2010]
"6 Swiss technologies to save the world - DNDi: the R&D oriented NGO" - "6 technologies suisses pour sauver le monde - DNDi: l'ONG orientée R&D" (French)
Click here to read the article
   

Press Articles

Nature.com [May 18, 2010]
"Neglected diseases fund touted"
Click here to read the article
   

Press Articles

Centre Daily News [May 5, 2010]
"White House needs to tackle all diseases"
Click here to read the article
   

Press Articles

The Lancet [April 2010, Vol 10]
"Building medical regulatory authorities in Africa"
Click here to read the article
   

Press Articles

Neue Zürcher Zeitung [February 19, 2010]
"New R&D models for most neglected diseases" - "Neue Forschungsmodelle für vernachlässigte Krankheiten" (German)
Click here to read the article
   

Press Articles

La Recherche [February, 2010]
"We develop innovative medicines for the poorest" - "Nous créons des médicaments innovants pour les plus pauvres" (French)
Click here to read the article
   

Press Articles

Le Point [February 1, 2010]
"Des maladies très fréquentes et pourtant négligées" (French)
Click here to access the article
   

Page 1 of 5

Press Contact
Media & Corporate
Communications

Eva van Beek
+41 22 906 92 50
+41 79 309 39 10
evanbeek@dndi.org


Except where otherwise noted, content on this site is licensed under
a Creative Commons Attribution-Noncommercial-Share Alike 2.5 Switzerland License